Government shares thought process behind final rules

Beth Walsh | | Health Exec | EMR/EHR

It was another busy week for Clinical Innovation + Technology with reporting from HIMSS' Big Data & Healthcare Analytics Forum as well as the November meeting of the Health IT Policy Committee, which addressed the final rules for Meaningful Use Stage 3 and the Certified EHR 2015 Edition, as well as the committee's report to Congress on interoperability.

Rob Anthony of the Centers for Medicare & Medicaid Services’ Quality Measurement and Value-Based Incentives Group, said the rule is aligned with a single set of overall goals for the program, including reducing the burden for providers.

The goal with the modifications to Stages 1 and 2 was to get everybody aligned to a set of objectives. By 2018, everybody on Medicare will be on full calendar year reporting.  

Meanwhile, Elise Sweeney Anthony, senior policy analyst at the Office of the National Coordinator for Health IT, said the Certified EHR 2015 Edition final rule is part of a wider effort to achieve the triple aim.

The rule builds on the foundation established by the 2011 and 2014 editions and addresses stakeholder feedback by reducing the burden on providers. “We took a real close look at the key pieces that would move interoperability and patient engagement forward,” Anthony said.

They wanted to make sure the criteria are beneficial to the behavioral health requirements CMS is putting forward in Meaningful Use Stage 3, and they wanted to create a more accessible program supportive of diverse health IT systems, including but not limited to EHR technology. That’s one reason there is no complete EHR criterion in the 2015 edition or in future editions. Going to an entirely modular program means providers can work more closely with their developer to tailor their systems.

I hope you found our coverage informative and insightful.

Beth Walsh

Clinical Innovation + Technology  editor

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup